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Introduction: Cancer tissue is composed of various stromal cells
forming cancer-specific microenvironments. Peritumoral stroma
is reportedly composed of activated fibroblasts that can influence
the biological properties of tumor cells, mainly their local ag-
gressiveness and their ability. The aim of this study was to
examine whether the histological properties of peritumoral
stroma are correlated with squamous cell carcinoma (SqCC)
aggressiveness and clinical outcome.
Methods: A series of 220 pathological stage I lung SqCC were
categorized into two types according to the histological properties of
the peritumoral stroma, “fibrous stroma type” (n  85), and “thin
stroma type” (n  135), and compared the prognostic significance.
Furthermore, we compared the immunohistochemical properties of
the SqCC cells surrounded by “fibrous stroma” with those of the
SqCC cells surrounded by “thin stroma.”
Results: The prognosis of the patients with fibrous stroma-type
tumors was significantly poorer than that of the thin stroma type
with regard to both recurrence-free survival (p  0.005) and overall
survival (p  0.008). A multivariate analysis showed that the
presence of a fibrous stroma was an independent prognostic factor
(p  0.030). Compared with the SqCC cells with a thin stroma, the
SqCC cells with a fibrous stroma exhibited reduced expression of
E-cadherin (55.9 versus 126.0, p  0.001) and an increased expres-
sion of laminin-52 (94.6 versus 25.0, p  0.001), matrix metallo-
proteinase-7 (26.0 versus 3.50, p  0.009), and c-Met (64.0 versus
36.5, p  0.033).
Conclusion: SqCC with a fibrous stroma displayed higher invasive
phenotype and were associated with a significantly poor prognosis.
The current results suggest that the microenvironment created by
both SqCC cells and the peritumoral fibroblasts may facilitate cancer
aggressiveness.
Key Words: Fibrous stroma, Epithelial mesenchymal transition,
Vascular invasion, Prognostic indicator, Squamous cell carcinoma.
(J Thorac Oncol. 2011;6: 1460–1467)
Non-small cell lung cancer (NSCLC) is the major cause ofcancer-related deaths throughout the world.1 Despite
advances in biological researches and therapeutic approaches,
the prognosis of patients with lung cancer remains unsatis-
factory. Indeed, approximately 30% of patients with patho-
logical stage I (p-stage I) NSCLC develop tumor recurrence
and die despite having undergone a complete surgical resec-
tion.2 The possibility that these patients may have occult
metastasis at the time of surgical treatment has been sug-
gested, highlighting the importance of evaluating the histo-
pathological and biological factors of NSCLC that are asso-
ciated with a poor prognosis.
Adenocarcinoma and squamous cell carcinoma (SqCC)
are the two major histological subtypes of NSCLC; however,
the pathogenesis and biological characteristics of these sub-
types differ. Although many reports have described the prog-
nostic markers for adenocarcinoma, few reports have men-
tioned prognostic markers for SqCC. Therefore, an analysis
of the prognostic markers for lung SqCC is likely to be
meaningful for the treatment of patients with these lesions.
Cancer tissue is composed of different kinds of stromal
cells forming cancer-specific microenvironments. The contri-
bution of cancer stromal fibroblasts (cancer-associated fibro-
blasts [CAFs]) to the development of a variety of tumors has
been supported by extensive clinical evidence and the use of
experimental mouse models.3–7 In adenocarcinoma, the ex-
pressions of Podoplanin and hypoxia marker carbonic anhy-
drase IX by CAFs are both correlated with conventional
prognostic factors and are unfavorable prognostic markers for
patients with lung adenocarcinoma.8,9 Although fibrosis is
generally found around cancer nests in lung SqCC, the
biological significance of CAFs is not fully understood, and
the influence of CAFs on cancer progression and aggressive-
ness has not been thoroughly investigated.
The aim of this study was to examine whether the
histological properties of peritumoral stroma are correlated
with the aggressiveness of SqCC. We first analyzed the
prognostic significance of the stromal fibrosis status and
found that the presence of a fibrous stroma surrounding the
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cancer nest was an independent indicator of a poor prognosis
and was correlated with the presence of vascular invasion.
Then, we examined the molecular properties of SqCC cells
surrounded by fibrous stroma that might influence cancer cell
biology.
Because a positive association between the presence of
“fibrous stroma” and the presence of vascular invasion was
observed in histological analysis, we hypothesized the fibrous
stroma could facilitate invasiveness and metastatic potential
of cancer cells. Therefore, we used the following antibodies
that had been reported being associated with cell motility and
invasive potential for immunohistochemistry: anti-E-cad-
herin, antilaminin-52, antifibronectin, anti-matrix metallo-
proteinase-7 (MMP-7), and anti-c-Met.
PATIENTS AND METHODS
Patients
During the period from January 1993 to August 2005,
a total of 2556 patients underwent surgical resection for
primary lung cancer at the National Cancer Center Hospital
East; the present study group is comprised of 220 consecutive
patients with SqCC of the lung who underwent a complete
resection and were diagnosed as having a p-stage I disease.
Institutional Review Board-approved informed consent was
obtained from all the patients. All the patients had a solitary
lesion, and patients who had received preoperative chemo-
therapy or preoperative thoracic radiation were excluded. The
preoperative evaluation included a physical examination, a
blood chemistry analysis, the measurement of tumor markers,
and bronchofiberscopy, chest radiography, and computed
tomography examinations of the chest. The majority of pa-
tients underwent a lobectomy or pneumonectomy for the
resection of the primary lesion. In cases of wedge resections
or segmentectomies, a lavage sample was obtained from the
surgical margin and evaluated using intraoperative rapid
cytology to confirm the absence of cancer cells.
Histopathologic Analysis
The available pathology slides from all 220 surgical
specimens were coded and masked for identity, then re-
viewed in this study by two pathologists (Y.T. and G.I.).
After fixing the specimens with either 10% formalin or cold
methanol and embedding them in paraffin, serial 4-m sec-
tions were stained with hematoxylin and eosin or Victoria
blue van Gieson to visualize the elastic fibers. The sections
stained using Victoria blue van Gieson were examined for the
presence of vascular invasion and pleural invasion. The cases
were reviewed according to the current World Health Orga-
nization histological classification10 and were staged accord-
ing to the tumor node metastasis classification of the Inter-
national Union Against Cancer.11 The following conventional
histopathological characteristics were evaluated: histological
differentiation, pleural invasion, vascular invasion, lymphatic
permeation, mitotic index, and pathological staging.
We further evaluated the following histological factors:
(1) the presence of fibrous stroma surrounding the cancer nest
and (2) the presence of stromal hyalinosis. Fibrous stroma
surrounding the cancer cell nests was defined as stroma
whose width was larger than some cancer nests and it was
intermingled with plump fibroblast and/or collagen fibers
(Figures 1A, B). When most cancer nests were separated from
FIGURE 1. Morphological features
of “fibrous stroma” and “thin
stroma” (hematoxylin and eosin
stained sections). A, “Fibrous stroma
type”: abundant stroma intermin-
gled with plump fibroblast and/or
collagen fibers are visible. B, Higher
magnification of “fibrous stroma
type.” C, “Thin stroma type”: the
cancer cell nests were separated
from each other by lymphoid
stroma. D, Higher magnification of
“thin stroma type”: a narrow
stroma composed of thin collagen-
fiber lamellae is visible.
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each other by a narrow stroma, which was less than cancer
nest in dimension measured in the same way, composed of
thin collagen-fiber lamellae or stroma consisted of infiltrative
lymphocytes, we categorized these stroma as “thin stroma”
(Figures 1C, D). We defined the “fibrous stroma type” cases
as those in which the predominant cancer nests were sur-
rounded by “fibrous stroma.” Meanwhile, if the stroma
around the cancer nests failed to fulfill this definition, the case
was regarded as a “thin stroma.” Stromal hyalinosis was
defined as the presence of cancer-induced stroma consisting
of mainly collagen fibers, most of which were hyalinized.
Variables for Prognostic Analysis
All available clinical information was obtained from
the clinical records. Central tumor location was defined as a
tumor location limited to the trachea, bronchi, or segmental
bronchi, and a peripheral tumor location was defined as a
tumor location limited more to the periphery than to the
subsegmental bronchi.12 The following clinicopathological
factors were assessed in a retrospective prognostic analysis:
age (70 years versus70 years), sex, smoking index (400
versus 400), forced expiratory volume in 1 second (FEV1.0)/
forced expiratory volume (70% versus 70%), serum squa-
mous cell carcinoma related antigen level (1.5 ng/mL
versus 1.5 ng/mL), tumor location (central versus periph-
eral), tumor diameter (30 mm versus 30 mm), histologi-
cal differentiation (well to moderately versus poorly), pleural
invasion (absence versus presence), vascular invasion (ab-
sence versus presence), lymphatic permeation (absence ver-
sus presence), mitotic index (10/10 high power field versus
10/10 high power field), cancer nest necrosis (10% versus
10%), stromal hyalinosis (absence versus presence), and
stroma type surrounding the cancer nest (thin stroma type
versus fibrous stroma type).
Antibodies and Immunohistochemistry
After the pathologic assessment of the hematoxylin and
eosin stained slides of the surgical specimens (all were
pathological T1 status), the 20 most representative slides of
the specimens that had been categorized as “fibrous stroma
type” or “thin stroma type” were selected for the further
analysis of each group. Sections (4 m) were cut from the
paraffin blocks and mounted on silanized slides. The sections
were deparaffinized in xylene and dehydrated in a graded
ethanol series. After washing in distilled water, the slides
were placed in 0.1 M of citric acid buffer. For antigen
retrieval, the slides were heated twice at 95°C for 20 minutes
in a microwave oven (H2800 Microwave Processor; Energy
beam Sciences, East Granby, CT) and then allowed to cool
for 1 hour at room temperature. The slides were washed three
times in phosphate-buffered saline (PBS) and immersed in a
0.3% hydrogen peroxidase solution in methanol for 15 min-
utes to inhibit endogenous peroxidase activity. After washing
the slides three times in PBS, nonspecific binding was
blocked by preincubation with 2% normal swine serum in
PBS (blocking buffer) for 30 minutes at room temperature.
Individual slides were then incubated overnight at 4°C with
the following antibodies: anti-E-cadherin (diluted 1:500,
clone 36; BD Bioscience, San Jose, CA), antilaminin-52
(1:200, clone D4B5; Chemicon, Temecula, CA), antifi-
bronectin (1:200, clone 568; Novocastra, Newcasyle upon
Tyne, UK), anti-MMP7 (1:100, clone 141-7B2; Daiichi Fine
Chemical, Toyama, Japan), and antic-Met (1:100; clone
8F11, Novocastra). The slides were again washed three times
in PBS and then incubated with EnVision (Dako, Glosstrup,
Denmark) for 1 hour at room temperature; after extensive
washing in PBS, they were visualized in 2% 3,3-diamino-
benzidine in 50 mM of Tris buffer (pH 7.6) containing 0.3%
hydrogen peroxidase. Finally, the slides were counterstained
with Meyer’s hematoxylin, dehydrated, and mounted. We
used positive control of each antibody in the immunohisto-
chemical study as follows: E-cadherin: bronchial epithelium,
laminin-52: basement membrane of bronchial epithelium,
fibronectin: connective tissue of alveolar septa, MMP7: hu-
man lung adenocarcinoma, and c-Met: bronchial epithelium.
Immunohistochemical Scoring
All the tissue sections that were stained were semiquan-
titatively scored and evaluated independently under a light
microscope, as previously described13; two pathologists (Y.T.
and G.I.) who had no clinicopathological information regard-
ing the cases performed the evaluations. The labeling score
was calculated by multiplying the percentage of positive
tumor cells in four high-power fields (200) from the most
representative areas of each slide (0–100%) by the staining
intensity level (0, negative; 1, weak; and 2, strong). We
confirmed that positive control tissues were stained by each
antibody. When the evaluation results differed between the
two observers, the specimens were examined using a multi-
headed-microscope, and a consensus was obtained.
Statistical Analysis
Overall survival (OS) was measured from the date of
surgery until the date of death from any cause or the date on
which the patient was last known to be alive. Survival curves
were plotted according to the Kaplan-Meier method and
compared using the log-rank test in a univariate analysis. The
recurrence-free survival (RFS) time was measured as the
interval between the date of surgery and the date of recur-
rence, or the date of death from any cause or the most recent
date on which the patient was last known to be alive. To
determine the independent prognostic factors, a multivariate
analysis was conducted using the Cox proportional hazard
model. Two category comparisons were performed using the
Pearson 2 test and the Mann-Whitney U test for quantitative
data. All the tests were two sided, and p values less than 0.05
were considered statistically significant. The statistical anal-
ysis was performed using SPSS software (version 11.0; SPSS
Inc., Chicago, IL).
RESULTS
Clinicopathological Characteristics of SqCC
Cases with “Fibrous Stroma”
We examined the clinicopathological characteristics of
the cases with fibrous stroma-type tumors (Table 1). A
peripheral tumor location (p  0.043), the presence of vas-
cular invasion (p  0.004), and the presence of stromal
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hyalinosis (p  0.002) were significantly more common
among the cases with fibrous stroma-type lesions.
Clinicopathological Characteristics and
Univariate Analysis of p-Stage I SqCC
The study cohort included 87 men and 76 women, with
a mean age of 69 years (range: 43–88 years; standard devi-
ation: 7.9 years). Nine (4.1%) of the 220 patients underwent
a wedge resection, 9 (4.1%) underwent a segmentectomy,
198 (90%) underwent a lobectomy, and 4 (1.8%) underwent
a pneumonectomy (data not shown). The follow-up periods
ranged from 4 to 150 months (the median follow-up for
surviving patients was 61 months).
The patients’ clinicopathological characteristics and the
results of a univariate analysis are shown in Table 2. A male
predominance and a high smoking status were notable char-
acteristics. The clinically significant survival predictors, as
shown using a univariate analysis, were age (70 years
versus 70 years, p  0.001) and tumor diameter (30 mm
versus 30 mm, p  0.031). Pathologically, 147 patients
(66.8%) had cancer nest necrosis accounting for less than
10% of the tumor, and 43 (19.5%) had stromal hyalinosis.
When the cases were divided into two groups according to the










70 65 38 0.618
70 70 47
Gender
Male 118 75 0.855
Female 17 10
Smoking index
400 12 10 0.489
400 123 75
Tumor location
Central 35 12 0.043
Peripheral 100 73
Tumor diameter (mm)
30 76 49 0.844
30 59 36
FEV1.0/FEV(%)
70 54 30 0.489
70 81 55
Histologic differentiation
Well to moderate 99 65 0.185
Poor 46 20
Pleural invasion
Absence 111 64 0.214
Presence 24 21
Vascular invasion
Absence 79 33 0.004
Presence 56 52
Lymphatic permeation
Absence 113 64 0.126
Presence 22 21
Mitotic index
10/10 HPF 93 57 0.777
10/10 HPF 42 28
Two-category comparison was performed by Pearson’s 2.
FEV1.0, forced expiratory volune in 1 second; FEV, forced expiratory volume; HPF,
high power field.
TABLE 2. Univariate Prognostic Analysis of
Clinicopathologic Factors
Factors N (%) 5-yr OS (%) p
Age (yr)
70 103 (46.8) 75.6 0.001
70 117 (53.2) 57.1
Gender
Male 193 (87.7) 66.2 0.780
Female 27 (12.3) 63.0
Smoking index
400 22 (10.0) 66.7 0.806
400 198 (90.0) 64.0
FEV1.0/FEV(%)
70 84 (38.2) 65.2 0.370
70 136 (61.8) 67.4
Serum SCC (ng/ml)
1.5 175 (79.5) 65.7 0.898
1.5 45 (20.5) 66.4
Tumor location
Central 47 (21.3) 72.0 0.095
Peripheral 173 (78.6) 64.2
Histologic differentiation
Well to moderate 154 (70.0) 66.0 0.601
Poor 66 (30.0) 65.9
Pleural invasion
Absence 175 (79.5) 69.4 0.045
Presence 45 (20.5) 51.8
Vascular invasion
Absence 112 (50.9) 72.7 0.140
Presence 108 (49.1) 58.7
Lymphatic permeation
Absence 177 (80.5) 67.1 0.669
Presence 43 (19.5) 60.5
Mitotic index
10/10 HPF 70 (31.8) 67.2 0.946
10/10 HPF 150 (68.2) 63.2
Cancer nest necrosis (%)
10 147 (66.8) 69.1 0.295
10 73 (33.2) 59.1
Stromal hyalinosis
Absence 177 (61.4) 67.2 0.380
Presence 43 (19.5) 60.2
Stroma type
Thin stroma type 135 (61.4) 72.3 0.008
Fibrous stroma type 85 (38.6) 55.5
Log-rank test was used in univariate analysis.
OS, overall survival; FEV1.0, forced expiratory volume in 1 second; FEV, forced
expiratory volume; SCC, squamous cell carcinoma; HPF, high power field.
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stroma type surrounding the cancer nest, the number of cases
with fibrous stroma was 85 (38.6%). A univariate prognostic
analysis of the pathological factors revealed that pleural
invasion (absence versus presence, p  0.045) and fibrous
stroma type (p  0.008) had prognostic significance. In
contrast, the other histological factors showed no prognostic
significance.
Survival Analysis According to Stroma Type
Figure 2A shows the RFS curves according to the
results of the examination for stroma type surrounding the
cancer nests (thin stroma type versus fibrous stroma type).
The 5-year RFS rates for the thin stroma type and the fibrous
stroma type were 70.0% and 50.0%, respectively. The RFS
time for the fibrous stroma type was significantly shorter than
that of the thin stroma type (p  0.0005). Figure 2B shows
the OS curves according to stroma type surrounding the
cancer nests. The 5-year OS rates of the cases with the thin
stroma type and the cases with the fibrous stroma were 72.3%
and 55.5%, respectively. The OS of the patients with the
fibrous stroma type was significantly shorter than that of the
patients with the thin stroma type (p  0.008).
Multivariate Analysis
To determine whether the presence of fibrous stroma
surrounding the cancer nests was an independently significant
prognostic factor, a multivariate analysis was performed. The
four clinicopathological factors that were shown to be impor-
tant survival predictors, as above, and the tumor location
were included as covariates in the multivariate analysis. As
shown in Table 3, the results showed that the age (70 years
versus 70 years, p  0.001) and the stroma type surround-
ing the cancer nests (thin stroma type versus fibrous stroma
type, p  0.030) were independent prognostic factors.
Molecular Properties of Cancer Cells
Surrounded by Fibrous Stroma
We performed immunohistochemical staining for the
following molecular markers: E-cadherin, laminin-52, fi-
bronectin, MMP7, and c-Met. The staining results are shown
in Table 4 and Figure 3. Immunoreactivity for E-cadherin
was found in the cytomembrane, and the mean staining scores
for the thin stroma type and the fibrous stroma type were
126.0 and 55.9, respectively (Figures 3A, B). The mean
staining scores for laminin-52, which was seen as positive in
the cytoplasm of cancer cells, in the cancer nests surrounded
by the thin stroma type and the fibrous stroma type were 25.0
and 94.6, respectively (Figures 3C, D).
Immunoreactivity for fibronectin was found in the cy-
toplasm of the cancer cells, and the mean staining scores in
FIGURE 2. A, Kaplan-Meier recurrence-free survival curve
for patients with pathological stage I (p-stage I) lung squa-
mous cell carcinoma (SqCC) according to stroma type sur-
rounding the cancer nests. B, Kaplan-Meier overall survival
curve for patients with p-stage I lung SqCC according to the
stroma type surrounding the cancer nests. Log-rank test was
used in both survival analysis.
TABLE 3. Multivariate Prognostic Analysis
Variables Favorable Unfavorable Hazard Ratio 95% CI p
Age (yr) 70 70 2.470 1.613–3.781 0.001
Tumor location Peripheral Central 1.142 0.665–1.959 0.631
Tumor diameter (mm) 30 30 1.368 0.915–2.045 0.126
Pleural invasion Absence Presence 1.182 0.701–1.992 0.531
Stroma type Thin stroma type Fibrous stroma type 1.541 1.042–2.277 0.030
Multivariate analysis was conducted using the Cox proportional hazard model.
CI, confidence interval.
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the thin stroma type and the fibrous stroma type were 8.41
and 26.1, respectively. MMP7 was also found in the cyto-
plasm of cancer cells, and the mean staining scores for the
thin stroma type and the fibrous stroma type were 3.50 and
26.0, respectively (Figures 3E, F). The expression of c-Met
could be clearly demonstrated in the cytoplasm of cancer
cells, and the mean staining scores for the thin stroma type
and the fibrous stroma type were 36.5 and 64.0, respectively
(Figures 3G, H).
The scoring for E-cadherin was significantly lower for
the fibrous stroma type than for the thin stroma type (p 
0.001). On the other hand, the laminin-52 (p  0.001),
MMP7 (p  0.009), and c-Met (p  0.033) expression levels
were significantly higher in the fibrous stroma type than in the
thin stroma type.
DISCUSSION
Although SqCC of the lung is a major histological
subtype of NSCLC, along with adenocarcinoma, the patho-
genesis and biological properties of lung SqCC are not well
understood. Whether any differences in the mechanism of
disease progression exist according to histological subtype
has also been unclear. Recent studies have suggested that
tumorigenesis and progression could be influenced by tumor-
associated stromal cells, including fibroblasts, leukocytes,
and endothelial cells, all of which contribute to variety in the
tumor microenvironment.14–16 Several proteins expressed by
CAFs may contribute to tumor aggressiveness, and may serve
as unfavorable prognostic markers in lung adenocarci-
noma.8,9 In addition, several reports have suggested that the
molecular properties of CAFs influence the biological fea-
tures of tumor cells and the outcomes of patients.17,18
In the current study, patients with pathological stage I
SqCC were selected because the early stage disease without
lymph node metastasis would reflect the cancer cell biology
more reliably. We found that the presence of fibrous stroma
surrounding the cancer nests was a significant indicator of a
poor prognosis and was correlated with the presence of
vascular invasion. Therefore, we hypothesized the fibrous
stroma could facilitate invasiveness and metastatic potential
of cancer cells and investigated the expression of markers
which had been reported being associated with cell motility
and invasive potential. Furthermore, these SqCC cells with
fibrous stroma exhibited a reduction in the expression of
E-cadherin and increases in the expressions of laminin-52,
c-Met, and MMP7, compared with the SqCC cells with thin
stroma.
TABLE 4. Immunohistochemical Staining Score According










E-cadherin 126.0  2.81 55.9  1.44 0.001
Laminin-52 25.0  1.16 94.6  3.52 0.001
Fibronectin 8.41  1.14 26.1  1.79 0.054
MMP7 3.50  0.42 26.0  1.00 0.009
C-Met 36.5  1.18 64.0  1.76 0.033
Mann-Whitney U test was used in comparison between the two groups.
FIGURE 3. Representative immunohistochemical findings
for “thin stroma type” and “fibrous stroma type.” A, E-cad-
herin expression in “thin stroma type.” Positive cells were
found in the cancer cell nests. B, E-cadherin expression in
“fibrous stroma type.” Only a few cancer cells showed posi-
tive reactions. C, Laminin-52 expression in “thin stroma
type.” Positive cells were not found. D, Laminin-52 expres-
sion in “fibrous stroma type.” A positive reaction was found
in the cytoplasm of the cancer cells. Note a few budding
cells around the cancer nest are also positive for laminin-
52. E, Matrix metalloproteinase-7 (MMP-7) expression in
“thin stroma type.” Positive cells were not found. F, MMP-7
expression in “fibrous stroma type.” Positive cells were
found, especially in the periphery of the cancer cell nests. G,
c-Met expression in “thin stroma type.” A few cancer cells
showed positive immunoreactions for c-Met. H, c-Met ex-
pression in “fibrous stroma type.” Positive cells were scat-
tered, especially at the periphery of the cancer cell nests.
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In general, tumor progression consists of multisteps,
which contain loss of epithelial junctions, increase of cell
motility, and invasiveness to surrounding organs and vessels.
And these steps should be caused by molecular changes of
cancer cells.19 Because a positive association between the
presence of “fibrous stroma” and the presence of vascular
invasion was observed, we examined expression of molecular
markers as above.
E-cadherin, a transmembrane glycoprotein, which is
essential for calcium-dependent intercellular adhesion.20
Fragments of laminin-52 chain is known to regulate cell
survive and migration.21 MMP7 has reported to be responsi-
ble for degradation of extra cellular matrix component and
play important role in tumor progression.22 The cancer cells
that were surrounded by fibrous stroma clearly exhibited a
reduced expression of E-cadherin and increased expressions
of laminin-52 and MMP7, corresponding to the molecular
features of increased motility and invasiveness.23 The current
immunohistochemical findings were also consistent with
those of a previous report that described a higher expression
of the similar markers, associated with a higher rate of vessel
invasion and a poor prognosis in patients with NSCLC.24 Our
results suggested that cancer cells surrounded by fibrous
stroma was possibly associated with a part of epithelial
mesenchymal transition, which is defined as a transformation
of epithelial cells into a mesenchymal cell-like morphology
with combined loss of epithelial cell junction proteins and a
gain of mesenchymal lineage marker expression, leading to
cells with increased motility.
Furthermore, we found the increased expression of
c-Met in SqCC cells with fibrous stroma. A transmembrane
tyrosine kinase, c-Met was identified as the receptor for
hepatocyte growth factor (HGF). HGF/c-Met signaling mod-
ulates cell spread and invasiveness, and the over expression
of c-Met facilitates the disruption of E-cadherin junctions.25
A recent study reported that an increase in HGF secretion
from CAFs activates c-Met in esophageal SqCC cells and that
this pathway promotes cell invasion to the matrix in three-
dimensional organotypic cultures. Moreover, the constitutive
activation of Met resulted in a phenotypic change in the cells,
with decreased cell-cell contact and increased mesenchymal
features such as an elongated cellular morphology.26 Our
results could be regarded as supporting these in vitro findings.
Tumor budding is a histological feature that is defined
as a single cell or clusters of up to four or five cancer cells at
the invasive tumor front.27 The process of tumor budding is
linked to the motile phenotype, which involves a reduction in
intercellular contacts and cell-matrix contacts and seems to be
the first event in tumor invasion and metastasis.28,29 Yama-
guchi et al.30 demonstrated that budding cells in lung adeno-
carcinoma displayed decrease expression of E-cadherin and
increase expression of laminin-52. In the current study,
cancer cells forming solid nests with fibrous stroma also
presented similar expression of markers, which indicated the
aggressiveness of tumor cells, even though they did not have
the morphological features of mesenchymal cells or tumor
budding (data not shown).
In conclusion, we clearly showed that SqCC with a
fibrous stroma type was associated with a poor prognosis
among patients with p-stage I lung SqCC after complete
resection. Elucidating whether the peritumoral stroma of lung
SqCC contributes to cancer progression would be meaningful
for the development of treatment targeting the tumor mi-
croenvironment and tailored to the histological subtype. Fur-
thermore, our findings also suggested that the microenviron-
ment created by SqCC cells and peritumoral fibrous stroma is
closely correlated with cancer aggressiveness, and this is the
first report to indicate that the nature of the stroma surround-
ing the cancer nests contributes to the tumor invasion and a
poor prognosis among lung SqCC cases. A more mechanis-
tically oriented experimental approach would be required for
elucidation of the mechanism and the key regulator(s) of the
interaction between SqCC cells and CAFs which lead to
useful therapeutic options in years to come.
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